Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Autoimmun. 2016 Feb 26;69:24–37. doi: 10.1016/j.jaut.2016.02.005

Fig. 1.

Fig. 1

Screening process for identification of candidate autoantigens. The approach for identification of HLA-DR-presented peptides in synovial tissue. The mass spectrum of the most immunoreactive peptide, which was derived from MMP-10, is shown in Screen 2.